Hepatitis C Virus NS3/4A Protease Inhibitor
5 drugs across 3 manufacturers|0 Generic,5 Brand
Total Drugs
5
0G / 5B
Manufacturers
3
Avg $390.2854/unit
Avg 7d Change
-0.02%
Across 3 drugs with changes
7d Activity
3↓2 flat
of 5 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
3 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VOSEVI 400-100-100 MG TABLET SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR | $858.6884 per EA | — |
ZEPATIER 50-100 MG TABLET elbasvir and grazoprevir | $634.2375 per EA | — |
MAVYRET 100-40 MG TABLET Glecaprevir and Pibrentasvir | $152.8336 per EA | -0.02% |
MAVYRET 100-40 MG TABLET Glecaprevir and Pibrentasvir | $152.8336 per EA | -0.02% |
MAVYRET 100-40 MG TABLET Glecaprevir and Pibrentasvir | $152.8336 per EA | -0.02% |